image
Exact Sciences Corporation EXAS
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 49.6
4.62 %
$ 9.21 B
Market Cap
-8.87
P/E
CASH FLOW STATEMENT
211 M OPERATING CASH FLOW
34.86%
Growth Rates
1Year 34.86%
3Years 59.52%
5Years 30.81%
7Years 25.62%
10Years 16.49%
-442 M INVESTING CASH FLOW
-890.02%
Growth Rates
1Year -890.02%
3Years 25.79%
5Years -29.57%
7Years -15.55%
10Years -14.14%
232 M FINANCING CASH FLOW
45.13%
Growth Rates
1Year 45.13%
3Years 201.36%
5Years -1.74%
7Years -1.67%
10Years -0.51%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Exact Sciences Corporation
image
Net Income -1.03 B
Depreciation & Amortization 215 M
Capital Expenditures -136 M
Stock-Based Compensation 215 M
Change in Working Capital 0
Others 820 M
Free Cash Flow 74.5 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
OPERATING CASH FLOW
Net Income (1 028.9) (204.1) (623.5) (595.6) (848.5) (84.0) (175.1) (114.4) (167.2) (157.8) (100.0) (46.5) (52.4) (28.7) (11.6) (9.1) (9.7) (12.0) (12.9) (14.5) (18.5) (28.3) (29.9) (23.5) (11.9) (5.0)
Depreciation & Amortization 214.9 206.6 197.6 180.3 163.4 50.2 23.1 15.6 11.5 7.8 3.7 1.4 1.0 0.4 0.2 0.2 0.6 (2.2) (3.0) (2.9) (2.8) 62 K 2.2 1.1 0.4 0.4
Deferred Income Tax (10.1) (1.0) (11.9) (253.2) (9.9) (185.1) (2.8) (0.1) 0.8 0.4 0.9 0.7 0.5 24.5 (5.3) 0 (1.4) (2.7) (3.0) (0.5) (0.5) (1.1) 0 0 0 0
Stock Based Compensation 214.9 231.3 206.8 339.2 152.9 108.5 60.3 35.5 23.7 18.1 11.5 7.7 5.5 4.3 2.2 2.6 1.0 2.8 3.0 0.5 0.5 1.1 0 0 0 0
Other Operating Activities 819.8 (76.4) 33.8 202.0 721.3 48.9 26.2 (0.6) (0.3) (0.5) (0.3) (4.1) (3.0) (28.6) 0.1 1.8 66 K 2.8 3.0 1.4 0.5 1.1 1.2 3.8 3.2 13.8 K
Change in Working Capital 0 (0.3) (26.4) 111.1 (42.7) (53.6) (0.9) (7.7) 1.5 (1.8) 3.3 1.5 4.2 0.2 0.8 (8.1) 1.5 2.5 0.8 47 K (0.4) 13.4 14.7 2.8 0.3 81.7 K
Cash From Operations 210.5 156.1 (223.6) (102.2) 136.5 (115.0) (69.3) (71.7) (130.1) (134.0) (80.9) (39.3) (44.2) (27.8) (13.5) (12.6) (7.9) (8.8) (12.2) (16.0) (21.2) (13.9) (11.9) (15.8) (8.0) (4.6)
INVESTING CASH FLOW
Capital Expenditures (136.0) (124.2) (214.5) (135.8) (64.4) (171.8) (150.7) (69.2) (14.9) (22.0) (12.5) (9.3) (0.7) (2.1) (0.6) (0.5) (0.1) (0.1) (0.4) (0.2) (0.3) (11.0) (1.3) (2.6) (0.8) (0.3)
Other Items (306.2) 173.9 288.5 (946.3) (637.7) 50.7 (631.2) (91.6) 3.3 (42.8) (105.3) (26.2) (37.6) (40.9) (14.3) (2.4) 8.4 8.2 4.9 16.0 (23.6) 20.5 (26.8) (2.0) (0.3) (0.4)
Cash From Investing Activities (442.2) 49.7 74.1 (1 082.1) (702.0) (121.1) (781.9) (160.8) (11.5) (64.8) (117.8) (35.5) (38.3) (43.0) (14.9) (2.9) 8.2 8.0 4.5 15.8 (23.9) 9.5 (28.1) (4.6) (1.1) (0.7)
FINANCING CASH FLOW
Common Stock Repurchased 31.2 28.3 25.5 23.1 0 8.4 4.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 K 8 K 0 0
Total Debt Repaid 216.8 138.0 50.0 (23.7) 974.2 236.1 920.7 (0.4) (0.2) 4.7 2.0 (0.3) (0.1) 0 0 1.0 0 0 0 0 0.4 58 K 0 0 0 6.4 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 15.1 21.8 26.5 32.2 43.7 17.1 13.5 7.9 5.5 3.0 242.0 1.8 2.4 0.7 2.9 17.4 0.1 100 K 0.2 0 0 0 0.2 337 81.5 K 4.07 K
Cash From Financing Activities 231.9 159.8 76.5 8.5 1 879.6 253.2 934.1 261.0 149.6 181.8 244.0 74.8 60.0 27.9 85.2 32.5 0.1 0.4 0.5 0.1 43.9 1.2 0.6 50.8 32.0 56.7 K
CHANGE IN CASH
Net Change In Cash (3.0) 366.9 (73.0) (1 175.8) 1 314.1 17.1 82.9 28.6 7.8 (17.0) 45.3 (0.5) (22.4) (43.0) 56.8 17.0 0.5 (0.3) (7.2) 85 K (1.1) (3.2) (39.4) 30.4 22.9 (5.3)
FREE CASH FLOW
Free Cash Flow 74.5 31.9 (438.0) (238.0) 72.1 (286.8) (220.0) (141.0) (144.9) (156.0) (93.4) (48.6) (44.8) (29.9) (14.1) (13.1) (8.0) (8.9) (12.5) (16.2) (21.5) (24.9) (13.3) (18.5) (8.8) (4.9)